Overall verdict
Neutral
5.7/10
1-year performance
+32.74%
Score breakdown
Up 32.7% over 1 year, 21% of the 52-week range.
Strongest: Shareholder return 6.6/10. Weakest: Profitability 2.8/10.
17 analysts, target +0.3% vs the price.
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK ; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors.
It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the company offers engineered products and integrated solutions for the non-residential, residential, and repair-and-remodel construction markets, includes TYVEK house wrap, STYROFOAM insulation, and CORIAN solid surface. Further, it engages in the design and production of engineered components, systems, and process solutions used in OEM and operational applications, such as automotive, aerospace, printing, and packaging.
Additionally, the company offers Vespel shapes and parts, MOLYKOTE specialty lubricants, BETAFORCE and BETASEAL structural adhesives, and Cyrel flexographic printing plates. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.
Sector
Industrials
Industry
Industrial Conglomerates
Primary listing
Nyse
United States
CEO
Lori Koch
Founded
2015
Employees
15 000
Revenue / employee
456 600 USD
Next earnings
November 4, 2026 (estimated)
Institutional holders
- BlackRock, Inc.7.88%
- VANGUARD CAPITAL MANAGEMENT LLC6.62%
- VANGUARD PORTFOLIO MANAGEMENT LLC4.74%
- Invesco Ltd.2.81%
- GEODE CAPITAL MANAGEMENT, LLC2.77%
- MORGAN STANLEY2.01%
- VICTORY CAPITAL MANAGEMENT INC1.74%
- GOLDMAN SACHS GROUP INC1.52%
- NORTHERN TRUST CORP1.19%
- Other institutions42.12%
- Rest of the register26.60%
1119 13F filings as of June 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
250.20 USD
52-week low
100.01 USD
1-year performance
32.74%
Rising
Year-to-date performance
7.88%
Rising
Drawdown
-47.69%
Major drawdown
Position in the 52-week range
21% of range
Against the world ETF
Over 17 years, from September 2009 to August 2026, the share did clearly worse than the world ETF once risk is accounted for. It earned less, while shaking 2.6 times harder.
10,000 € placed at the end of September 2009 are worth today
| DuPont de Nemours | 7 211 € |
| World ETF | 74 620 € |
| S&P 500 | 123 025 € |
| Risk-free placement | 11 288 € |
The risk
- Shaking:the share moves 2.6 times as much as the world ETF.
- Worst fall:-86 % between January 2018 and March 2020. 10,000 € placed at the top fell to 1 395 €. The world ETF, at worst: -34 %. The share has not returned to its high yet.
DuPont de Nemours earned less than the world ETF since 2009
Value of 10,000 euros placed at the end of September 2009, dividends reinvested, in euros
- DuPont de Nemours: 7 211 €
- World ETF: 74 620 €
- S&P 500: 123 025 €
- Risk-free placement: 11 288 €
Share price without dividends; the world ETF and the index reinvest theirs. A dividend payer is therefore understated here.
Based on past performance. This is not a recommendation.
Range: 9.70 USD - 167.30 USD (comparables only)
The price implies growth of 2.75% per year; the company grows at -10.00%.
Gross margin 32.7%, net margin 6.2%, ROIC 2.2%, ROE 2.8%.
Net margin
6.19%
Fair
Sector 7.58%|S&P 12.97%
Gross margin
32.74%
Exceptional
Return on equity (ROE)
2.78%
Low
Sector 8.60%|S&P 16.52%
Return on invested capital (ROIC)
2.24%
Low
Free cash flow margin (FCF)
12.69%
Exceptional
Profit-to-cash conversion (FCF conversion)
2.05x
Exceptional
Margin stability
20.2 pts
Very uneven
Revenue to net income
Growth
6.5/10Revenue up 4.0% over 1 year, -13.7% a year over 5.
Revenue (trailing 12 months)
8.3Md USD
Revenue growth (1y)
4.00%
Moderate
Revenue growth (3y)
-47.38%
Declining
EPS growth (1y)
147.88%
Hyper-growth
EPS CAGR (5y)
—
EPS revisions (3 months)
1.33%
Revised up
Valuation
4.9/10P/E 310.9x, forward P/E 24.6x, EV/EBITDA 9.6x, PEG 2.10. The multiple sits in the 54th percentile of its own 5-year history.
P/E (TTM)
310.9x
Very expensive
Sector 15.2x|S&P 23.0x
Forward P/E
24.6x
Fair
EV / EBITDA
9.6x
Fair
Sector 12.0x|S&P 14.5x
PEG
2.10
Very expensive
Sector 0.97|S&P 0.86
Fair value (reverse DCF)
88.50 USD
Deeply overvalued
P/E vs its own 5-year history
among the 46% highest valuations
In line with its history
Market cap
17.7Md USD
Financial strength
5.8/10Cash covers 57.0% of the debt, net debt/EBITDA 1.8x.
Net debt / EBITDA
1.8x
Very solid
Gearing (net debt / equity)
9.68%
Stretched
Cash
1.8Md USD
Cash / market cap
10.08%
Solid
Cash / total debt
57.02%
Solid
Net debt
1.3Md USD
Equity
13.9Md USD
Closed daily candles, 2 years
Last close on September 24, 2026: 130.22 USD
- MM20130.59
- MM50136.26
- MM200137.41
- RSI 1444.5
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+0.98%
200-day average slope, 3 months
-11.07%
50-day average slope, 1 month
-2.34%
Price structure
Lower lows
Bullish RSI divergence
No
20-day volatility
1.31 % per day
Volatility change
-29.06%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 5.33 (3) | 7.26 (15) | 7 166 (15) | 1 763 (16) | 720 (3) |
| 2027 | 6.15 (3) | 7.96 (16) | 7 449 (15) | 1 874 (16) | 813 (3) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of September 11, 2026.
Same sub-industry: 79 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | A402340 | 8.0 | 7.6 | 114Md USD | 5.4x | 2665.9 % | -7.6 % | 85.5 % | — | — | 450.9 % | ||
| 2 | A028260 | 7.0 | 6.2 | 41.5Md USD | 21.5x | 6.4 % | 19.7 % | 3.9 % | -0.7x | 5.9 % | 83.5 % | ||
| 3 | 1 | 6.9 | 5.6 | 33.0Md USD | 6.9x | 13.6 % | -0.5 % | 4.5 % | 2.9x | 18.3 % | 33.8 % | ||
| 4 | SIE | 6.5 | 5.8 | 238Md USD | 27.4x | 9.7 % | 7.3 % | 7.3 % | 3.3x | 4.9 % | 20.6 % | ||
| 5 | 6501 | 6.3 | 6.0 | 158Md USD | 31.1x | 7.2 % | 20.0 % | 11.6 % | -0.2x | 5.2 % | 35.4 % | ||
| 6 | MMM | 5.9 | 5.9 | 87.8Md USD | 30.2x | 11.9 % | 2.5 % | 19.0 % | 1.2x | 4.5 % | 7.4 % | ||
| 7 | HON | 5.8 | 6.0 | 67.4Md USD | 7.9x | 22.1 % | 4.2 % | 18.6 % | 2.6x | 6.2 % | 2.5 % | ||
| 8 | DuPont de NemoursAnalysed | DD | 5.7 | 5.0 | 17.7Md USD | 310.9x | 6.2 % | 4.0 % | 2.2 % | 1.8x | 5.9 % | 32.7 % | |
| 9 | 267 | 4.0 | 4.0 | 48.5Md USD | 5.6x | 7.6 % | 3.0 % | 4.0 % | 12.6x | 140.8 % | 13.8 % |
